Can a drug save Insulin-Making cells in kids with new diabetes?

NCT ID NCT03782636

First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 22 times

Summary

This study tests a drug called aldesleukin to see if it can help children and young adults (ages 6-18) recently diagnosed with type 1 diabetes keep making their own insulin. Participants are split into two groups: one gets the drug, the other gets a placebo. The goal is to measure how well the body still produces insulin over six months, while also checking safety and immune cell changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Addenbrooke's Hospital

    Cambridge, United Kingdom

  • Bristol Royal Hospital for Children

    Bristol, United Kingdom

  • Nottingham Children's Hospital

    Nottingham, United Kingdom

  • Oxford Children's Hospital

    Oxford, Oxfordshire, OX3 9DU, United Kingdom

  • The Great North Children's Hospital

    Newcastle upon Tyne, United Kingdom

Conditions

Explore the condition pages connected to this study.